Indraprastha Medical Corporation Ltd
Incorporated in 1988 as a JV between Apollo Hospitals Enterprise Ltd. (AHEL) and the Delhi Government, Indraprastha Medical Corporation Ltd. is a super speciality tertiary care hospital in New Delhi. The Co. currently has 52 speciality departments. [1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE 1000 BSE Hospitals
Quarterly Results
Figures in Rs. Crores
(S): Standalone figures, shown where consolidated figures are not available.
Profit & Loss
Figures in Rs. Crores
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 714 | 755 | 766 | 753 | 788 | 831 | 613 | 888 | 1,099 | 1,245 | 1,356 | 1,483 | |
| Sales growth | +5% | +6% | +1% | -2% | +5% | +5% | -26% | +45% | +24% | +13% | +9% | +9% |
| 630 | 675 | 686 | 678 | 706 | 743 | 572 | 768 | 947 | 1,050 | 1,112 | 1,215 | |
| Operating Profit | 85 | 80 | 79 | 74 | 82 | 87 | 41 | 120 | 152 | 195 | 245 | 267 |
| OPM % | 12% | 11% | 10% | 10% | 10% | 11% | 7% | 14% | 14% | 16% | 18% | 18% |
| 1 | 1 | -0 | -1 | -1 | -0 | -0 | -3 | 9 | 16 | 22 | 28 | |
| Interest | 8 | 7 | 8 | 9 | 7 | 6 | 3 | 3 | 4 | 4 | 6 | 6 |
| Depreciation | 28 | 35 | 31 | 31 | 30 | 33 | 33 | 35 | 39 | 40 | 44 | 44 |
| Profit before tax | 50 | 39 | 41 | 34 | 45 | 48 | 4 | 79 | 117 | 166 | 216 | 246 |
| Tax % | 34% | 37% | 36% | 38% | 36% | 9% | 46% | 26% | 26% | 25% | 26% | 25% |
| 32 | 24 | 26 | 21 | 28 | 44 | 2 | 59 | 86 | 124 | 161 | 184 | |
| EPS in Rs | 3.54 | 2.66 | 2.86 | 2.30 | 3.10 | 4.76 | 0.25 | 6.39 | 9.40 | 13.52 | 17.56 | 20.03 |
| Dividend Payout % | 51% | 68% | 63% | 65% | 52% | 0% | 0% | 39% | 32% | 33% | 26% | 20% |
(S): Standalone figures, shown where consolidated figures are not available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | Sep 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 | 92 |
| Reserves | 103 | 132 | 139 | 141 | 152 | 176 | 181 | 234 | 288 | 386 | 505 | 649 | 723 |
| 50 | 52 | 67 | 66 | 21 | 4 | 3 | 5 | 2 | 34 | 33 | 37 | 35 | |
| 196 | 185 | 160 | 134 | 157 | 177 | 157 | 131 | 173 | 212 | 222 | 214 | 269 | |
| Total Liabilities | 442 | 460 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 723 | 852 | 991 | 1,118 |
| 286 | 301 | 296 | 294 | 280 | 303 | 283 | 277 | 275 | 347 | 328 | 365 | 387 | |
| CWIP | 3 | 3 | 0 | 0 | 1 | 0 | 3 | 0 | 3 | 0 | 33 | 3 | 3 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 142 |
| 153 | 157 | 163 | 138 | 141 | 146 | 145 | 185 | 278 | 376 | 491 | 624 | 586 | |
| Total Assets | 442 | 460 | 458 | 432 | 422 | 449 | 432 | 462 | 555 | 723 | 852 | 991 | 1,118 |
(S): Standalone figures, shown where consolidated figures are not available.
Cash Flows
Figures in Rs. Crores
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 64 | 62 | 28 | 48 | 75 | 86 | 27 | 94 | 144 | 200 | 157 | 167 | |
| -29 | -33 | -22 | -30 | -17 | -40 | -19 | -74 | -108 | -158 | -111 | -178 | |
| -35 | -30 | -5 | -17 | -44 | -43 | -3 | -3 | -26 | -32 | -46 | -46 | |
| Net Cash Flow | -0 | -0 | -0 | 1 | 14 | 4 | 5 | 17 | 11 | 9 | -0 | -57 |
| Free Cash Flow | 35 | 29 | 5 | 17 | 58 | 46 | 6 | 65 | 100 | 131 | 120 | 108 |
| CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit | 98% | 104% | 57% | 82% | 110% | 113% | 88% | 95% | 102% | 127% | 89% | 88% |
(S): Standalone figures, shown where consolidated figures are not available.
Ratios
| Mar 2015 (S) | Mar 2016 (S) | Mar 2017 (S) | Mar 2018 (S) | Mar 2019 (S) | Mar 2020 (S) | Mar 2021 (S) | Mar 2022 (S) | Mar 2023 (S) | Mar 2024 (S) | Mar 2025 (S) | Mar 2026 (S) | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 40 | 41 | 47 | 41 | 35 | 35 | 40 | 18 | 23 | 17 | 20 | 28 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 40 | 41 | 47 | 41 | 35 | 35 | 40 | 18 | 23 | 17 | 20 | 28 |
| Working Capital Days | -35 | -22 | -17 | -7 | -5 | -10 | -1 | -2 | -12 | -24 | -19 | -4 |
| ROCE % | 23% | 18% | 17% | 15% | 19% | 21% | 3% | 29% | 34% | 38% | 39% | 36% |
(S): Standalone figures, shown where consolidated figures are not available.
Insights
In beta| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Average Length of Stay (ALOS) days ・Standalone data |
|
||||||||||
| Discharges (Inpatient Volumes) count ・Standalone data |
|||||||||||
| Out-patients (OPD Visits) count ・Standalone data |
|||||||||||
| Revenue per Bed Day (ARPOB) Rs. ・Standalone data |
|||||||||||
| Revenue per Patient Rs. ・Standalone data |
|||||||||||
| Bed Occupancy Rate % ・Standalone data |
|||||||||||
| Total Operational Beds beds ・Standalone data |
|||||||||||
| International Patients Share of Revenue % ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Clarification On Increase In Volume
- Company clarifies no undisclosed information behind recent share volume increase.
-
Clarification sought from Indraprastha Medical Corporation Ltd
- Exchange has sought clarification from Indraprastha Medical Corporation Ltd on November 17, 2026, with reference to Movement in Volume.
-
Announcement under Regulation 30 (LODR)-Change in Management
- Mr. Shivakumar Pattabhiraman ceased as Managing Director effective 4 November 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
- We hereby submit copies of the public notice of the financial results published on 30th October 2026, in the Financial Express all India edition in …
-
Board Meeting Outcome for Outcome Of Board Meeting- Un-Audited Financial Results For The Quarter Ended 30-09-2026
- Board approved unaudited results for quarter and half-year ended 30 September 2026.
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from bse
-
Annual Report 2024
from bse
-
Annual Report 2023
from bse
-
Annual Report 2022
from bse
-
Annual Report 2021
from bse
-
Annual Report 2020
from bse
-
Annual Report 2019
from bse
-
Annual Report 2018
from bse
-
Annual Report 2017
from bse
-
Annual Report 2016
from bse
-
Annual Report 2014
from bse
-
Annual Report 2013
from bse
-
Annual Report 2012
from bse
-
Annual Report 2012
from nse
Parentage[1] [2] [3]
The company was incorporated as a joint venture between Apollo Hospitals Enterprise Ltd. (AHEL) and the Government of Delhi. As of Jun 2026, AHEL holds a 22% stake, while the Delhi Government holds a 26% stake in the company. Apollo Hospitals is a leading healthcare player that owns and operates the largest hospital chain in the country. Its network spans over 78 hospitals, 7,289 pharmacies, 2,501 diagnostic centres, more than 300 clinics and over 200 telemedicine centres